# ECG Validation Study

> **NCT05445726** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Analog Device, Inc.** · enrollment: 141 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** CPM Device

## Key facts

- **NCT ID:** NCT05445726
- **Lead sponsor:** Analog Device, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-19
- **Primary completion:** 2022-09-02
- **Final completion:** 2023-11-01
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2023-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05445726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05445726, "ECG Validation Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05445726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*